PRA said it signed an agreement with equity firm Genstar Capital to
be bought back by the firm for around $790m (€580m) while the CRO
posted a 90 per cent tumble in profit in Q2 due to heavy
Pfizer, Novartis and Sanofi-Aventis were the companies who
attracted the most interest from pharmaceutical business
researchers in the first half of the year, according to a UK pharma
market research firm.
One-off costs related to last year's acquisition of Serologicals
and a continuing manufacturing consolidation strategy were largely
responsible for sharp falls in Millipore's pre-tax and net profits
for the first quarter...
An increasing number of factors are luring sponsors to offshore
clinical trials to 'hidden gems' across the globe, delegates heard
at this week's Accelerating Patient Recruitment & Retention in
Clinical Trials conference,...
More companies in the pharmaceutical industry than any other
industry are set to increase their reliance on information
technology (IT) and business process (BP) outsourcing this year,
new research indicates.
A new report out this week suggests the pharma industry is losing
the trust of its key stakeholders. The report, compiled by
PricewaterhouseCoopers (PwC), concludes that the growing decline in
the pharmaceutical industry's reputation...
Although US spending on healthcare rose by 6.9 per cent in 2005,
taking it to almost $2 trillion (€1.5 trillion), it's the smallest
increase since 1999, down from 7.2 per cent in 2004 and 8.1 per
cent in 2003.
A recent report that focuses on international research and
development trends has placed China as the country gaining
significant grounds on the US in terms of R&D spending and
Fresh from Thermo's $10.4bn (€8.3bn) acquisition of the scientific
equipment and instrument specialists, Fisher Scientific posted
strong third quarter results that showed a profit rise of 62 per
cent coupled with an 11 per cent...
Two trade associations of the world's two largest pharma economies
- Europe and the US - took the unusual step of banding together at
the CPhI in Paris to condemn their regulatory authorities for poor
regulation of foreign active...
Portuguese drug producers are small and need to merge or form
alliances to compete at a global level, investing more in
innovation and increasing their competitiveness like custom
manufacturer Hovione has done, a new report by market...
Difficulties in identifying tablets have emerged as a major issue
in a recent US survey of 150 pharmacists who are warning drugmakers
that the lack of distinct appearance in pills leads in dispensing
errors that cost more than 7,000...
Europe's third party logistics providers (3PL) are evolving to
integrate more of their operations with those of their clients in a
bid to provide a more efficient service, leaving the old breed in
danger of becoming extinct.
Italian packaging and processing machinery company IMA Group has
posted a net profit of €13m for 2005, down 24 per cent from 2004,
since a rise in revenues was offset by one-off charges, operating
costs and a reduction in prices as...
According to a new report, the pharmaceutical market grew seven per
cent, to $602 billion (€501 billion) in 2005. The report
highlighted the emerging markets including China, Korea, Mexico,
Russia and Turkey, which experienced double-digit...
Despite a dip in revenue, PRA International saw its profit grow 53
per cent in the fourth quarter of 2005 to reach $7.5m (€6.3m) on
the back of improved margins. The global clinical research
organization (CRO) also saw a similar growth...
Quest Diagnostics, the US's leading provider of diagnostic testing,
information and services announced better than expected fourth
quarter results after increased clinical testing activity helped to
offset a weakness in its test...
French pharmaceutical company, Sanofi-Aventis, reported an increase
in sales for the fourth quarter with its vaccine business
continuing to impress. The company's performance precedes two
upcoming decisions later this year that...
Covance closed 2005 on a high after net revenues climbed 16.9 per
cent from 2004 to reach $1.19 bn (€1 bn). The current trend towards
outsourcing R&D, coupled with increased productivity and repeat
business has fuelled the company's...
Drug production company Patheon has released its fourth-quarter
results, which has revealed that profit has jumped 180 per cent
despite a recent production halt at a Puerto Rican subsidiary. This
bodes well for the recent manufacturing...
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.